Literature DB >> 16874296

Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Nicole M Smith, Joseph S Bresee, David K Shay, Timothy M Uyeki, Nancy J Cox, Raymond A Strikas.   

Abstract

This report updates the 2005 recommendations by the Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and antiviral agents (CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2005;54[No. RR-8]:1--44). The 2006 recommendations include new and updated information. Principal changes include 1) recommending vaccination of children aged 24-59 months and their household contacts and out-of-home caregivers against influenza; 2) highlighting the importance of administering 2 doses of influenza vaccine for children aged 6 months--<9 years who were previously unvaccinated; 3) advising health-care providers, those planning organized campaigns, and state and local public health agencies to a) develop plans for expanding outreach and infrastructure to vaccinate more persons than the previous year and b) develop contingency plans for the timing and prioritization of administering influenza vaccine, if the supply of vaccine is delayed and/or reduced; 4) reminding providers that they should routinely offer influenza vaccine to patients throughout the influenza season; 5) recommending that neither amantadine nor rimantadine be used for the treatment or chemoprophylaxis of influenza A in the United States until evidence of susceptibility to these antiviral medications has been re-established among circulating influenza A viruses; and 6) using the 2006-07 trivalent influenza vaccine virus strains: A/New Caledonia/20/1999 (H1N1)-like, A/Wisconsin/67/2005 (H3N2)-like, and B/Malaysia/2506/2004-like antigens. For the A/Wisconsin/67/2005 (H3N2)-like antigen, manufacturers may use the antigenically equivalent A/Hiroshima/52/2005 virus; for the B/Malaysia/2506/2004-like antigen, manufacturers may use the antigenically equivalent B/Ohio/1/2005 virus. A link to this report and other information can be accessed at http://www.cdc.gov/flu.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16874296

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  171 in total

1.  Multicomponent interventions to enhance influenza vaccine delivery to adolescents.

Authors:  Lisa M Gargano; Karen Pazol; Jessica M Sales; Julia E Painter; Christopher Morfaw; LaDawna M Jones; Paul Weiss; James W Buehler; Dennis L Murray; Gina M Wingood; Walter A Orenstein; Ralph J DiClemente; James M Hughes
Journal:  Pediatrics       Date:  2011-10-10       Impact factor: 7.124

2.  Meditation or exercise for preventing acute respiratory infection: a randomized controlled trial.

Authors:  Bruce Barrett; Mary S Hayney; Daniel Muller; David Rakel; Ann Ward; Chidi N Obasi; Roger Brown; Zhengjun Zhang; Aleksandra Zgierska; James Gern; Rebecca West; Tola Ewers; Shari Barlow; Michele Gassman; Christopher L Coe
Journal:  Ann Fam Med       Date:  2012 Jul-Aug       Impact factor: 5.166

3.  Prioritizing healthcare worker vaccinations on the basis of social network analysis.

Authors:  Philip M Polgreen; Troy Leo Tassier; Sriram Venkata Pemmaraju; Alberto Maria Segre
Journal:  Infect Control Hosp Epidemiol       Date:  2010-09       Impact factor: 3.254

4.  Highlights of the National Advisory Committee on Immunization statement on influenza for the 2006-2007 season.

Authors:  Joanne M Langley
Journal:  CMAJ       Date:  2006-09-26       Impact factor: 8.262

Review 5.  Influenza vaccination: policy versus evidence.

Authors:  Tom Jefferson
Journal:  BMJ       Date:  2006-10-28

6.  Managing drugs and devices in patients with permanent ventricular assist devices.

Authors:  Martin Cadeiras; Manuel von Bayern; Mario C Deng
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

Review 7.  Immunogenetics of seasonal influenza vaccine response.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

8.  Influenza-related hospitalization and ED visits in children less than 5 years: 2000-2011.

Authors:  Astride Jules; Carlos G Grijalva; Yuwei Zhu; H Keipp Talbot; John V Williams; Katherine A Poehling; Sandra S Chaves; Kathryn M Edwards; William Schaffner; David K Shay; Marie R Griffin
Journal:  Pediatrics       Date:  2014-12-08       Impact factor: 7.124

9.  Discrete Dynamical Modeling of Influenza Virus Infection Suggests Age-Dependent Differences in Immunity.

Authors:  Ericka Keef; Li Ang Zhang; David Swigon; Alisa Urbano; G Bard Ermentrout; Michael Matuszewski; Franklin R Toapanta; Ted M Ross; Robert S Parker; Gilles Clermont
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

10.  Humoral and cellular immune responses to influenza vaccination in children with cancer receiving chemotherapy.

Authors:  Rosa María Wong-Chew; Margarita Nava Frías; Miguel Leonardo García-León; Lourdes Arriaga-Pizano; Aurora Medina Sanson; Constantino Lopez-Macías; Armando Isibasi; José Ignacio Santos-Preciado
Journal:  Oncol Lett       Date:  2012-05-17       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.